Cargando…
Stability Study of Isoniazid and Rifampicin Oral Solutions Using Hydroxypropyl-Β-Cyclodextrin to Treat Tuberculosis in Paediatrics
(1) Background: First-line antituberculosis treatment in paediatrics entails the administration of Isoniazid, Pyrazinamide, and Rifampicin. This study examines the possibility of developing a combined dose liquid formulation for oral use that would facilitate dose adjustment and adherence to treatme...
Autores principales: | Santoveña-Estévez, Ana, Suárez-González, Javier, Cáceres-Pérez, Amor R., Ruiz-Noda, Zuleima, Machado-Rodríguez, Sara, Echezarreta, Magdalena, Soriano, Mabel, Fariña, José B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076452/ https://www.ncbi.nlm.nih.gov/pubmed/32102447 http://dx.doi.org/10.3390/pharmaceutics12020195 |
Ejemplares similares
-
A pharmaceutical monitoring system to assess the quality of antituberculosis drug products used in Mauritania
por: Cáceres-Pérez, Amor R., et al.
Publicado: (2023) -
In Vivo Investigation of (2-Hydroxypropyl)-β-cyclodextrin-Based Formulation of Spironolactone in Aqueous Solution for Paediatric Use
por: Lopalco, Antonio, et al.
Publicado: (2022) -
Fatal poisoning by isoniazid and rifampicin
por: Sridhar, A., et al.
Publicado: (2012) -
Isoniazid- and rifampicin-induced thrombocytopenia
por: Yakar, Fatih, et al.
Publicado: (2013) -
Development and Optimization of a New UPLC-UV/MS Method through DoE and MLR for Detecting Substandard Drug Products to Treat Tuberculosis
por: Suárez-González, Javier, et al.
Publicado: (2022)